
Echoing F.D.A. concerns, the state’s top prosecutor accused Park Avenue Stem Cell of charging thousands of dollars for unproven, unregulated treatments. REED ABELSON https://ift.tt/2FSOelT https://ift.tt/2UiiUqY The New York Times Health Stem Cells, Suits and Litigation (Civil), Regulation and Deregulation of Industry April 4, 2019 at 12:00AM
Comments
Post a Comment